United States · FDA National Drug Code directory
Pindolol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10135-743_4a2bd5cb-bdc6-a71d-e063-6394a90a9a53
- Product NDC
- 10135-743
- Form
- TABLET
- Composition / generic term
- Pindolol
- Labeler
- Marlex Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220601
- Source listing expiry
- 20271231
Source-listed ingredients
- PINDOLOL — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (10135-743-01) · 10135-743-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →